Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions
International Journal of Molecular Sciences · 06.12.2024 · 25 (23) · 13115
DOI: 10.3390/ijms252313115 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.12.2024. Verfasst von Vanna Denti und 17 weiteren Autor:innen. Beteiligte Einrichtung: Proteomics and Metabolomics Unit, Department of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy. Hauptthemen laut MEDLINE: Mutation, Thyroid Neoplasms, Proteomics, ras Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of the University MUR Dipartimenti di Eccellenza 2023-2027 IMPACT MEDICINE Project (IMPACT MEDICINE, l. 232/2016, art. 1, commi 314 - 337), National Plan for NRRP Complementary Investments (PNC), Directorial Decree n. 931 of 06-06-2022 - project n. PNC0000003 - AdvaNced Technologies for Human-centr…, Ricerca Finalizzata.
Abstract (Originalsprache)
Follicular-patterned thyroid neoplasms comprise a diverse group of lesions that pose significant challenges in terms of differential diagnosis based solely on morphologic and genetic features. Thus, the identification of easily testable biomarkers complementing microscopic and genetic analyses is a highly anticipated advancement that could improve diagnostic accuracy, particularly for noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTPs). These tumors exhibit considerable morphological and molecular heterogeneity, which may complicate their distinction from structurally similar neoplasms, especially when genetic analyses reveal shared genomic alterations (e.g., RAS mutations). Here, we integrated next-generation sequencing (NGS) with matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) to perform a proteogenomic analysis on 85 NIFTPs (n = 30 RAS-mutant [RAS-mut] and n = 55 RAS-wild type [RAS-wt]), with the aim to detect putative biomarkers of RAS-mut lesions. Through this combined approach, we identified four proteins that were significantly underexpressed in RAS-mut as compared to RAS-wt NIFTPs. These proteins could serve as readily accessible markers in morphologically borderline cases showing RAS mutations. Additionally, our findings may provide insights into the distinct pathogenic pathways through which RAS-mut and RAS-wt NIFTPs arise, highlighting the pivotal role of constitutive RAS–mitogen-activated protein kinase (MAPK) pathway activation in the development and progression of RAS-mut tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Proteomics and Metabolomics Unit, Department of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
- Department of Medicine and Surgery, Pathology, Center of Digital Medicine, University of Milano-Bicocca, Fondazione IRCCS San Gerardo dei Tintori, Via Cadore 48, 20900 Monza, Italy.
- Bicocca Bioinformatics Biostatistics and Bioimaging Research Centre-B4, Department of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
- Biostatistics and Clinical Epidemiology, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
- Department of Pathology and Laboratory Medicine, European Institute of Oncology IRCCS, 20141 Milan, Italy.
- Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
ORCID-Profile: Vanna Denti, Antonio Maria Alviano, Giulia Capitoli, Andrew Smith, Mariia Ivanova, Fausto Maffini, Stefania Galimberti, Fulvio Magni, Nicola Fusco, Vincenzo L'Imperio, Fabio Pagni
Förderung
- Italian Ministry of the University MUR Dipartimenti di Eccellenza 2023-2027 IMPACT MEDICINE Project (IMPACT MEDICINE, l. 232/2016, art. 1, commi 314 - 337)
- National Plan for NRRP Complementary Investments (PNC), Directorial Decree n. 931 of 06-06-2022 - project n. PNC0000003 - AdvaNced Technologies for Human-centr…
- Ricerca Finalizzata
- National Plan for NRRP Complementary Investments
- research initiatives for technologies and innovative trajectories in the health and care sectors
Zitieren
APA
Denti, V., Greco, A., Alviano, A. M., Capitoli, G., Monza, N., Smith, A., Pilla, D., Maggioni, A., Ivanova, M., Venetis, K., Maffini, F., Garancini, M., Pincelli, A. I., Galimberti, S., Magni, F., Fusco, N., L'Imperio, V., & Pagni, F. (2024). Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions. International Journal of Molecular Sciences, 25(23), 13115. https://doi.org/10.3390/ijms252313115
Vancouver
Denti V, Greco A, Alviano AM, Capitoli G, Monza N, Smith A, et al. Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions. International Journal of Molecular Sciences. 2024;25(23):13115. doi:10.3390/ijms252313115
BibTeX
@article{Denti2024,
author = {Denti, Vanna and Greco, Angela and Alviano, Antonio Maria and Capitoli, Giulia and Monza, Nicole and Smith, Andrew and Pilla, Daniela and Maggioni, Alice and Ivanova, Mariia and Venetis, Konstantinos and Maffini, Fausto and Garancini, Mattia and Pincelli, Angela Ida and Galimberti, Stefania and Magni, Fulvio and Fusco, Nicola and L'Imperio, Vincenzo and Pagni, Fabio},
title = {Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {23},
pages = {13115},
doi = {10.3390/ijms252313115}
}
EUVIMED